↓ Skip to main content

Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial

Overview of attention for article published in BMC Medicine, May 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
5 Mendeley